Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic
JERSEY CITY, N.J., June 10, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell & Gene Therapy Supply Chain Software Market Size, Share & Trends Analysis Report By Business Type (Transport, Warehouse, Distribution, Value-Added Services), Mode Of Operation (Storage, Roadways, Seaways), And End Use, Region, Market Outlook And Industry Analysis 2031".
https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
The Cell & Gene Therapy Supply Chain Software Market is poised for significant growth, projected to surpass USD 668.4 Mn by 2031, with a promising CAGR of 13.9% during the forecast period.
Enhanced therapies, including cell and gene therapy products, have reformed healthcare practices. The prevalence of such therapeutic options has led to an uprise shift in modern medicine's development, production, and consumption. Moreover, such therapies have established healthcare providers to treat several rare clinical conditions.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2520
Supply chain software in this sector encompasses solutions for inventory management, logistics, temperature monitoring, and regulatory compliance. It facilitates the coordination of multiple stakeholders, including manufacturers, contract research organizations (CROs), logistics providers, and healthcare facilities. Investments in R&D are also essential for advancing technological innovations and raising the caliber of produced goods.
Furthermore, the market's future potential appears bright because of the growing use of digitalization. Various software solutions play crucial roles in these processes, including cell rearrangement platforms, Enterprise-manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems.
List of Prominent Key Players in the Cell and Gene Therapy Supply Chain Software Market:
-- Azenta Life Sciences
-- Biocair
-- BioLife Solutions
-- CareDx
-- Cryoport
-- Lonza
-- NMDP BioTherapies
-- TraceLink
-- TrakCel
-- Veeva Systems
-- Emerson
-- LabVantage Solutions
-- Marken
-- MasterControl
-- QuickSTAT
-- Siemens
-- Stafa Cellular Therapy
-- Steiner
-- STEMSOFT Software
-- TECHNICAL
-- Thermo Fisher Scientific
-- Other Prominent Players
Cell and Gene Therapy Supply Chain Software Market Scope:
Report Attribute
Specifications
Market Size Value In 2023
USD 240.5 Mn
Revenue Forecast In 2031
USD 668.4 Mn
Growth Rate CAGR
CAGR of 13.9% from 2024 to 2031
Quantitative Units
Representation of revenue in US$ Mn, and CAGR from 2024 to 2031
Historic Year
2019 to 2023
Forecast Year
2024-2031
Report Coverage The forecast of revenue, the position of the company, the competitive market structure,
growth prospects, and trends
Segments Covered By Process Component, Type of Software, Mode of Deployment, Type of End-User, And Scale of
Operation
Regional Scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain;
Southeast Asia; South Korea
Order 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2520
Market Dynamics:
Drivers-
Several key factors drive the Cell and Gene Therapy Supply Chain Software Market. Primarily, the rising demand for personalized medicine and advanced therapies fuels the need for efficient supply chain management solutions. Also, the complexity of cell and gene therapy manufacturing requires sophisticated software to ensure product quality and compliance with regulatory standards. In addition, the rising number of clinical trials and commercial launches of these therapies boosts demand for software that can accommodate the unique challenges of their supply chains. Lastly, the COVID-19 pandemic has underscored the importance of resilient supply chains, driving further interest in software solutions to enhance agility and visibility.
Challenges:
The Cell & Gene Therapy Supply Chain Software Market faces several challenges. The high cost of developing and implementing specialized software poses a barrier to entry for smaller companies. Also, regulatory complexities and stringent compliance requirements add layers of difficulty to software development and usage. Interoperability issues between different systems can hinder seamless data exchange and integration. Lastly, the need for continuous adaptation to evolving technologies and industry standards presents ongoing challenges for software providers and users alike, requiring constant updates and enhancements to meet the dynamic needs of the cell and gene therapy sector.
Regional Trends:
North America is a leading region in the biotechnology and pharmaceutical industries, boasting a robust ecosystem of companies specializing in cell and gene therapy research, development, and manufacturing. The region's leading software companies and technology hubs further enhance its position. This comprehensive overview of regional trends is crucial for regulatory authorities to stay informed and make informed decisions.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2520
Recent Developments:
-- In January 2024, Veeva Systems partnered with SK Biopharmaceuticals to
optimize the former company's quality management system and decrease the
risks involved with quality assurance of regenerative healthcare
medicine.
-- In Nov 2023, Cryoport, Inc. announced its acquisition of Tec4med
LifeScience GmbH. Cryoport's acquire of Tec4med is a significant step in
broadening their range of condition monitoring solutions, fostering new
product development, and accelerating European market penetration,
notably in the DACH area (Germany, Austria, Switzerland).
-- In June 2023, Biocair has integrated TrakCel's software with OCELLOS to
increase customer service, automation, and visibility in the cell and
gene therapy (CGT) supply chain.TrakCel's advanced therapeutic
orchestration platform OCELLOS streamlines the cell, gene, and
immunotherapy supply chain. To scale cell and gene therapy development,
the platform tracks chain of identification and custody. This lets
stakeholders track orders in transit.
Segments of Cell and Gene Therapy Supply Chain Software Market -
By Process Component-
-- Sample Collection and Processing Component
-- Manufacturing Component
-- Logistics Component
-- Patient Identification and Treatment Follow-up Component
By Type of Software-
-- Enterprise Manufacturing System (EMS)
-- Laboratory Information Management System (LIMS)
-- Inventory Management System (IMS)
-- Cell Orchestration Platform (COP)
-- Quality Management System (QMS)
-- Logistics Management System (LMS)
-- Patient Management System (PMS)
By Mode of Deployment-
-- On-premises Deployment
-- Cloud-based Deployment
By Type of End-User-
-- Pharmaceutical Companies
-- Cell Therapy Labs
-- Hospitals / Medical Centers
-- Research Institutes / Biobanks
By Scale of Operation-
-- Clinical Scale
-- Commercial Scale
By Region-
North America-
-- The US
-- Canada
-- Mexico
Europe-
-- Germany
-- The UK
-- France
-- Italy
-- Spain
-- Rest of Europe
Asia-Pacific-
-- China
-- Japan
-- India
-- South Korea
-- Southeast Asia
-- Rest of Asia Pacific
Latin America-
-- Brazil
-- Argentina
-- Rest of Latin America
Middle East & Africa-
-- GCC Countries
-- South Africa
-- Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/2520
Why should buy this report:
-- To receive a comprehensive analysis of the prospects for global Cell and
Gene Therapy Supply Chain Software market
-- To receive industry overview and future trends of global Cell and Gene
Therapy Supply Chain Software market
-- To analyze the Cell and Gene Therapy Supply Chain Software market
drivers and challenges
-- To get information on the Cell and Gene Therapy Supply Chain Software
market size value (US$ Mn) forecast till 2031
-- Major Investments, Mergers & Acquisition in global Cell and Gene Therapy
Supply Chain Software industry
Other Related Reports Published by InsightAce Analytic:
AI in Patient Management Market
Digital Pharmaceutical Supply Chain Management Market
AI in Medical Supplies/Inventory Management Market
Patient Engagement Solutions Market
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic PVT. LTD
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Follow us on LinkedIn: https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/cell--gene-therapy-supply-chain-software-market-expected-to-grow-at-a-13-9-cagr-from-2024-2031--latest-report-by-insightace-analytic-302168218.html
SOURCE InsightAce Analytic Pvt. Ltd
